Scoring method

Scoring method

Public scores are calculated from facts in the Ministry of Health, Labour and Welfare's directory, including the plan review level, number of registered technologies, coverage of technology areas and order records. The weights and calculations are shown below.

The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →

Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive

01 · Calculation

The public score is calculated from public registration information and does not reflect quality of care.

Class I and II plans require review by a specially certified committee for regenerative medicine. Class I plans also undergo confirmation by the Minister of Health, Labour and Welfare.

A Plan classification30
B Registered technologies35
C Areas covered25
D Class I / Class II · Registered technologies10

−20 · Order deduction

Score componentsPublic scoreCalculation
A · Plan classification30Class I: 30; Class II: 25; Class III: 10
B · Registered technologies3535 × min(1, log₂(1 + N) / log₂(21))
C · Areas covered2525 × min(D, 7) / 7
D · Class I / Class II · Registered technologies1010 × min(1, log₂(1 + M) / log₂(11))
− · Order deduction20−20

max(0, A + B + C + D − Order deduction) → 0–100 · 0.1

N
N is the number of distinct technology names after NFKC normalization and whitespace removal. The same technology is counted once across plan classes.
D
D is the number of areas covered. Of the ten areas, stem cells and the adipose, umbilical cord and bone marrow subareas count as one together; each other area counts separately, giving seven areas in all; full marks require all seven.
M
M is the number of distinct technology names in Class I or II plans. The same technology is counted once across plan classes.

The plan-level component uses only the highest review level among the classes of plans the institution has submitted; levels are not added together.

If the order column is non-empty in any row for an institution, 20 points are deducted; otherwise the deduction is zero. This is an archived record and does not establish the current situation.

The total is calculated from unrounded components and then rounded to one decimal place. Components are displayed to one decimal place, so their displayed values may not add up exactly to the total.

Total scores are shown to one decimal place. Every institution has its own rank: when totals are equal, institutions are ordered by registered technologies, then Class I and II technologies, then areas covered, then the number of public plan documents, and finally by Japanese name. Area rankings compare technologies registered in that area right after the total score.

Calculation example

EIMY CLINIC ↗ · N = 2 · D = 2 · M = 1

A · Review level
25.0
B · Technologies
12.6
C · Coverage
7.1
D · Class I / II technologies
2.9
Order deduction
−0.0

25 + 12.6297… + 7.142857142857143 + 2.8906… − 0

The total is calculated from unrounded components and then rounded to one decimal place. Components are displayed to one decimal place, so their displayed values may not add up exactly to the total.

Total score47.7/ 100

02 · Technology areas

Original technology names are normalized using NFKC and matched against regular expressions without regard to Latin-letter case. A technology may belong to multiple areas; unmatched names are recorded as Other. Rules marked AND depend on a ganxibao match. Plan class comes from the institution's registration record, not from the area.

Plan classification · RegExp
Technology areasRegExp · NFKC · i
Stem cells (all sources)幹\)?細胞|間葉系|MSC|SVF|間質血管細胞|ADSC
Adipose-derived stem cells脂肪 ∧ ganxibao
Umbilical cord-derived

No technologies named with the term 臍帯 were found in this directory archive, so there is no separate ranking for this category.

臍帯
Bone marrow-derived骨髄 ∧ ganxibao
PRP and platelet-derivedPRP|多血小板|血小板
NK and immune cellsNK|ナチュラルキラー|LAK|CTL|Lymphocyte|免疫細胞|樹状細胞|αβT|γδT|T細胞|リンパ球|樹状
Joints and musculoskeletal関節|整形外科|運動器|半月板|軟骨|腱|靭帯|靱帯|骨折|腰痛|(?<!心)筋(?!萎縮性側索硬化)
Hair毛髪|育毛|発毛|脱毛症|薄毛|AGA|頭皮
Dental歯|歯周|歯槽|口腔
Skin皮膚|皮フ|皮ふ|しわ|シワ|肌|ざ瘡|瘢痕|美容

03 · Data scope

The register lists 4,464 entries; after merging duplicate entries for the same institution, 3,858 institutions remain.

Records are merged only when the institution names match after NFKC normalization and whitespace removal, and the prefecture and normalized municipality and street-number address also match. Address normalization standardizes numbers and address formats. Where a match cannot be confirmed, records remain separate rather than being merged on subjective judgment.

1,736 institutions have a profile page. 1,294 of them are open to search engines; the other 442 carry less information and are not submitted to search engines for now.

An institution receives a profile if it has at least one technology in the stem-cell area, at least two registered technologies, or has submitted a Class I or II plan. Profiles are eligible for search-engine indexing if they have at least two registered technologies or matching first-party supplementary information. No supplementary list is available for this round, so the remaining profiles carry less information and are not submitted to search engines for now. All institutions with a profile are included in the rankings.

All institutions are ranked using the same algorithm, with no extra points, preferential placement, or paid ranking.

Data is updated when the Ministry of Health, Labour and Welfare's public directory is collected again.

The public score does not include treatment outcomes, case counts, physician credentials, facility conditions, prices or reputation. Cell-processing facility lists and plan registration dates are not publicly available and are therefore excluded from scoring. Information not found in public records should not be assumed absent.

04 · What else to consider

← Ranked by public registration data
One-to-one advice

Still unsure? Ask an advisor

Use the “Chat with an advisor” button on this page (at the bottom of the screen on mobile, bottom right on desktop) to open a chat with the Stem Cell Japan advice desk. Consultation and coordination are free, and an advisor replies within one working day.

Chat with an advisor